Since both Ano1 and ER can be inhibited by tamoxifen, the finding that Ano1 that has tumor-promoting properties is associated with good prognosis in breast cancer patients receiving tamoxifen resembles the fact that ER that promotes breast cancer growth is associated with good prognosis in patients following tamoxifen treatment [38]. Here, ANO1 is linked to breast carcinoma.